Merck & Co., Inc. MRK
NYSE
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 8.90% | 1.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.90% | 1.97% | |||
| Cost of Revenue | 6.90% | 6.53% | |||
| Gross Profit | 9.56% | 0.55% | |||
| SG&A Expenses | -0.40% | 8.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -29.63% | 66.49% | |||
| Operating Income | 16,025.00% | -100.64% | |||
| Income Before Tax | 913.91% | 80.67% | |||
| Income Tax Expenses | -24.77% | -7.76% | |||
| Earnings from Continuing Operations | 478.98% | 68.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -200.00% | -33.33% | |||
| Net Income | 479.40% | 68.51% | |||
| EBIT | 16,025.00% | -100.64% | |||
| EBITDA | 451.89% | -81.43% | |||
| EPS Basic | 479.70% | 68.49% | |||
| Normalized Basic EPS | 1,253.95% | -108.63% | |||
| EPS Diluted | 477.43% | 68.58% | |||
| Normalized Diluted EPS | 1,249.26% | -108.63% | |||
| Average Basic Shares Outstanding | -0.08% | -0.08% | |||
| Average Diluted Shares Outstanding | 0.32% | -0.08% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 1.26% | -2.23% | |||